platinum has been researched along with sphingosine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandla, A; Chang, JK; Chayaburakul, K; Chew, WS; Herr, DR; Lam, BWS; Lopez, V; Ong, WY; Seow, WL; Sundar, R; Torta, F; Wang, W; Wenk, MR; Wong, P; Xiang, P | 1 |
1 other study(ies) available for platinum and sphingosine
| Article | Year |
|---|---|
Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy.
Topics: Animals; Antineoplastic Agents; Axons; Biomarkers; Cisplatin; Female; Humans; Lysophospholipids; Myelin Sheath; Neuroglia; PC12 Cells; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2020 |